Acute Pancreatitis clinical trials

Explore recruiting acute pancreatitis clinical trials.

Recruiting acute pancreatitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Pancreatitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pancreatitis and early omega-3-fatty acid infusion for reduction of organ failure and mortality: a multicenter randomized controlled trial (PLANCTON).

Netherlands, Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Normal saline versus lactated Ringer’s solution for fluid administration in acute pancreatitis, an open-label multicenter randomized controlled trial: the WATERLAND trial

Hungary

Therapeutic use (Phase IV) EU CTIS Study details

ISIS 678354-CS13: An Open-Label Extension Study of AKCEA-APOCIII-LRX Administered Subcutaneously to Patients with Familial Chylomicronemia Syndrome (FCS)

Sweden, Spain, Slovakia, Netherlands, Portugal, Italy +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial

Netherlands, Finland, Sweden, Italy, Norway, Belgium +1 more

Therapeutic use (Phase IV) EU CTIS Study details

Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis (SHASTA-5 Study)

Hungary, Bulgaria, Sweden, Austria, Norway, Belgium +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Normal saline versus lactated Ringer’s solution for acute pancreatitis resuscitation, an open-label multicenter randomized controlled trial: the WATERLAND trial

Spain, France

Therapeutic use (Phase IV) EU CTIS Study details

Acute Pancreatitis trials by city

Acute Pancreatitis in Toronto Acute Pancreatitis in Vancouver Acute Pancreatitis in Montreal Acute Pancreatitis in Calgary Acute Pancreatitis in Edmonton Acute Pancreatitis in Ottawa Acute Pancreatitis in Winnipeg Acute Pancreatitis in Quebec City Acute Pancreatitis in Hamilton Acute Pancreatitis in Kitchener Acute Pancreatitis in London Acute Pancreatitis in Halifax Acute Pancreatitis in New York Acute Pancreatitis in Los Angeles Acute Pancreatitis in Chicago Acute Pancreatitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease